Loading
Life sciences · Journal article
Pyramid Journal of Medicine · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
A high level of adherence to Antiretroviral Treatment (ART) of at least 95% is needed for optimal suppression of Human Immunodeficiency Virus (HIV)’s RNA. Non-adherence's consequences have severe implications for managing People Living with HIV (PLHIV). Adherence predicts virologic outcomes in a dose-dependent manner. Depression is the most prevalent psychiatric disorder among PLHIV with a prevalence of 17% in Sub-Saharan Africa (SSA). To determine and compare the prevalence of non-adherence to Antiretroviral (ARV) drugs among depressed and non-depressed patients with HIV on ART. The study was conducted in Kano, Nigeria, at an HIV clinic located within a tertiary hospital. The study was a comparative cross-sectional study that enrolled 130 depressed and 130 non-depressed PLHIV. Statistically significant associations were found between depression and ART regimen type, Central Penetration Effectiveness (CPE), and pill burden. The prevalence of non-adherence among HIV depressed was 29.3%, while it was 23.6% among non-depressed using the adherence questionnaire. Depressed HIV patients have less adherence compared to non-depressed patients. It is recommended that consultation-liaison psychiatry is integrated into HIV treatment and care.